© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
August 08, 2020
In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.
August 07, 2020
In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.
June 29, 2020
Where do investigators go next with the 8000-plus COPD patient research?
June 26, 2020
Both dosage groups of the study drug achieved at least a 50-meter increase from baseline to week 24 on the six-minute walk distance test.
June 25, 2020
Treatment with treprostinil of up to 12 breaths per session four-times per data was well-tolerated, with a safety profile consistent with previous studies.
In an era of triple therapy combinations, what might a tailored approach look like?
June 24, 2020
New findings from the 8000-plus patient ETHOS trial shows triple inhaler therapy siginificantly betters patient mortality and symptoms over 52 weeks versus dual therapy.
May 27, 2020
How clinical data for the interleukin-targeting class will begin to dictate more treatement decisions and research progression.
May 24, 2020
Asthmatic infants often suffer from other comorbidities throughout their lives.
May 23, 2020
Blood eosinophil count, exacerbation rate, and time to exacerbation were all bettered among patients who sustained therapy versus those who discontinued.